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Study Purpose 
 
  I test the hypothesis that a ROE weighted  
portfolio of Healthcare stocks (20) will outperform 
The Healthcare sector ETF (XLV) and the  
S&P500 ETF (SPY). 
 
• Research Design 
• Develop ROE based weighted portfolio for 
     top 20 stocks in the XLV sector 
• Weighting Strategy 
• Relative Standard Deviation Model 
1. Wi= S.D. ROEi / S.D. ROE(B) 
 
2. Di=Wi x 1,000,000 
 
3. SHRit=Dit/ Pit 
 
4. MVi(t+1)=SHRitxPi(t+1) 
 
5. PORT(t+1)=∑MVi(t+1) 
 
• Nomenclature 
• Wi=Portfolio Weight 
• Di=Dollar Investment 
• SHRi=Shares Held 
• MVi=Market Value 
• PORT=Portfolio Value 
• i=(ith)stock 
• B=Benchmark Portfolio 
• t=time: 2011-2015 
• Pi=Price of Stocki 
• S.D. ROE=Standard Deviation(ROE) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1
Cumulative Returns: Buy and Hold
ROE XLV SPY
2011 14.18% 10.13% 2.06%
2012 48.79% 26.61% 18.23%
2013 139.39% 76.01% 56.31%
2014 210.35% 117.09% 77.46%
2015 228.48% 128.68% 79.83%
Table 2
Cumulative Returns: Rebalance
ROE XLV SPY
2011 14.18% 10.13% 2.06%
2012 48.37% 26.61% 18.23%
2013 129.82% 76.01% 56.31%
2014 190.37% 117.09% 77.46%
2015 205.61% 128.68% 79.83%
Conclusion 
• ROE model (B/H) outperforms XLV and 
SPY over five year period 
• ROE model (Reb) outperforms XLV and 
SPY over five year period 
• B/H model outperforms Reb model 
 
